Later this week the FDA will tackle the question of whether or not blood clots can form within drug-coated stents designed the prevent the growth of scar tissue. The most important question experts must answer is whether the benefits of drug-coated stents outweigh the small potential risks associated with the devices. Report (WSJ sub. req.)